Literature DB >> 21522162

Calculating occupancy when one does not have baseline: a comparison of different options.

Euitae Kim1, Oliver D Howes, Kyung-Sang Yu, Jae Min Jeong, Jae Sung Lee, In-Jin Jang, Sang-Goo Shin, Shitij Kapur, Jun Soo Kwon.   

Abstract

Dopamine D(2) receptor occupancy of antipsychotic drugs is calculated relative to the subject's D(2) receptor binding potential (BP) in the drug-free state (baseline BP). Because baseline BP is seldom known in patients with schizophrenia, population means from unrelated control samples are often used to estimate it. However, this is likely to introduce bias and error into the occupancy measure. There is thus a need for a method to reliably estimate baseline BP for patient populations in whom it may be impractical or unethical to get baseline measurements. It has been previously found that the relationship between plasma concentration and dopamine receptor occupancy by antipsychotic drugs follows a sigmoid E(max) model. Based on this, we developed a method for calculating dopamine D(2) receptor occupancy by antipsychotic drugs using an inhibitory E(max) model (I(max) method) that estimates individual baseline BPs. To validate this, we compared the result from the I(max) method with actual occupancy and estimated occupancy calculated from the average baseline BP (substitution method). The data for validation were obtained from two different receptor occupancy studies with the antipsychotic medications YKP1358 and aripiprazole. We estimated the reliability between the true measured occupancy and the predicted occupancy using the intraclass correlation coefficient (ICC), and the variability of occupancy was also compared between the I(max) and substitution methods. In YKP1358 study, all the ICCs of the I(max) method were above 0.8, but those of the substitution method showed values lower than 0.8. In aripiprazole study, the ICCs of the I(max) method were higher than those of the substitution method, but all the ICCs showed higher values than 0.8. The variability of I(max) method was significantly smaller than that of substitution method in both studies. The I(max) method shows better reliability and less variability than the substitution method. The I(max) method can be applied for receptor occupancy study, and bring more reliability and accuracy to the occupancy study in patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21522162      PMCID: PMC3170949          DOI: 10.1038/jcbfm.2011.54

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  33 in total

1.  Significant dissociation of brain and plasma kinetics with antipsychotics.

Authors:  Johannes Tauscher; C Jones; G Remington; R B Zipursky; S Kapur
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

2.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

3.  Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.

Authors:  T Lee; P Seeman; W W Tourtellotte; I J Farley; O Hornykeiwicz
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

4.  Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.

Authors:  Lawrence S Kegeles; Anissa Abi-Dargham; W Gordon Frankle; Roberto Gil; Thomas B Cooper; Mark Slifstein; Dah-Ren Hwang; Yiyun Huang; Suzanne N Haber; Marc Laruelle
Journal:  Arch Gen Psychiatry       Date:  2010-03

Review 5.  Imaging dopamine transmission in schizophrenia. A review and meta-analysis.

Authors:  M Laruelle
Journal:  Q J Nucl Med       Date:  1998-09

6.  A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.

Authors:  Gary Remington; David Mamo; Alain Labelle; Jeffrey Reiss; Chekkera Shammi; Erik Mannaert; Steve Mann; Shitij Kapur
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

7.  Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding.

Authors:  H Ito; J Hietala; G Blomqvist; C Halldin; L Farde
Journal:  J Cereb Blood Flow Metab       Date:  1998-09       Impact factor: 6.200

8.  Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia.

Authors:  Ryosuke Arakawa; Hiroshi Ito; Akihiro Takano; Hidehiko Takahashi; Takuya Morimoto; Takeshi Sassa; Katsuya Ohta; Motoichiro Kato; Yoshiro Okubo; Tetsuya Suhara
Journal:  Psychopharmacology (Berl)       Date:  2007-12-06       Impact factor: 4.530

9.  D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.

Authors:  L Farde; F A Wiesel; S Stone-Elander; C Halldin; A L Nordström; H Hall; G Sedvall
Journal:  Arch Gen Psychiatry       Date:  1990-03

Review 10.  Functional neuroimaging in schizophrenia: diagnosis and drug discovery.

Authors:  Philip McGuire; Oliver D Howes; James Stone; Paolo Fusar-Poli
Journal:  Trends Pharmacol Sci       Date:  2008-01-09       Impact factor: 14.819

View more
  5 in total

1.  Relationship between subjective well-being and aripiprazole: an [11C]raclopride PET study.

Authors:  Seoyoung Kim; Elena Younhye Ock; Jun Soo Kwon; Euitae Kim
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

2.  Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings.

Authors:  Marco Pozzi; Dario Cattaneo; Sara Baldelli; Serena Fucile; Annalisa Capuano; Carmela Bravaccio; Liberata Sportiello; Silvana Bertella; Fabiana Auricchio; Renato Bernardini; Carmen Ferrajolo; Giuseppe Guastella; Elisa Mani; Carla Carnovale; Simone Pisano; Concetta Rafaniello; Maria Pia Riccio; Renata Rizzo; Maria Grazia Scuderi; Serena Sperandeo; Laura Villa; Antonio Pascotto; Massimo Molteni; Francesco Rossi; Sonia Radice; Emilio Clementi
Journal:  Eur J Clin Pharmacol       Date:  2015-11-28       Impact factor: 2.953

3.  The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [11C]-raclopride PET study with aripiprazole.

Authors:  Sangho Shin; Seoyoung Kim; Seongho Seo; Jae Sung Lee; Oliver D Howes; Euitae Kim; Jun Soo Kwon
Journal:  Transl Psychiatry       Date:  2018-04-24       Impact factor: 6.222

4.  Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia.

Authors:  Kimberly E Vanover; Robert E Davis; Yun Zhou; Weiguo Ye; James R Brašić; Lorena Gapasin; Jelena Saillard; Michal Weingart; Robert E Litman; Sharon Mates; Dean F Wong
Journal:  Neuropsychopharmacology       Date:  2018-10-26       Impact factor: 7.853

5.  The use of healthy volunteers instead of patients to inform drug dosing studies: a [¹¹C]raclopride PET study.

Authors:  Euitae Kim; Oliver D Howes; Bo-Hyung Kim; Kyung-Sang Yu; Jae Min Jeong; Jae Sung Lee; Su Jin Kim; In-Jin Jang; Jung Shin Park; Yong Gil Kim; Sang-Goo Shin; Federico E Turkheimer; Shitij Kapur; Jun Soo Kwon
Journal:  Psychopharmacology (Berl)       Date:  2011-04-19       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.